Véronique Abitbol (Veronique Abitbol)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Escherichia Coli

Clinical Practice

Nursing Students

Top Venues

Human vaccines & immunotherapeutics

Expert review of vaccines

Infectious diseases and therapy

Pathogens and global health

This page only lists publications with an associated author ORCID identifier.

Publications

Véronique Abitbol, Federico M Torres, Muhamed-Kkeir Taha, Terry M Nolan, Alessandro Muzzi, Stefania Bambini, Ray Borrow, Daniela Toneatto, Laura Serino, Rino Rappuoli, Mariagrazia Pizza
4CMenB journey to the 10-year anniversary and beyond. Human vaccines & immunotherapeutics 20 (1) (2024)
Véronique Abitbol, Federico M Torres, Muhamed-Kkeir Taha, Terry M Nolan, Alessandro Muzzi, Stefania Bambini, Ray Borrow, Daniela Toneatto, Laura Serino, Rino Rappuoli, Mariagrazia Pizza
4CMenB journey to the 10-year anniversary and beyond. Human vaccines & immunotherapeutics 20 (1) (2024)
Véronique Abitbol, Federico M Torres, Muhamed-Kkeir Taha, Terry M Nolan, Alessandro Muzzi, Stefania Bambini, Ray Borrow, Daniela Toneatto, Laura Serino, Rino Rappuoli, Mariagrazia Pizza
4CMenB journey to the 10-year anniversary and beyond. Human vaccines & immunotherapeutics 20 (1) (2024)
Muhamed-Kkeir Taha, Rafik Bekkat-Berkani, Véronique Abitbol
Changing patterns of invasive meningococcal disease and future immunization strategies. Human vaccines & immunotherapeutics (2023)
Ray Borrow, Federico Martinón-Torres, Véronique Abitbol, Anar Andani, Scott Preiss, Alessandro Muzzi, Laura Serino, Woo-Yun Sohn
Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness. Expert review of vaccines 22 (1) (2023)
Véronique Abitbol, Woo-Yun Sohn, Michael Horn, Marco Aurélio Palazzi Safádi
Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review. Human vaccines & immunotherapeutics 19 (2) (2023)
Anand P Dubey, Rashna Dass Hazarika, Véronique Abitbol, Shafi Kolhapure, Someya Agrawal
Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India. Human vaccines & immunotherapeutics 18 (1) (2022)
Muhamed-Kkeir Taha, Federico M Torres, Ralph Köllges, Paolo Bonanni, Marco Aurélio Palazzi Safádi, Robert Booy, Vinny Smith, Stéphanie Garcia, Rafik Bekkat-Berkani, Véronique Abitbol
Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease. Expert review of vaccines 21 (5) (2022)
Federico M Torres, Muhamed-Kkeir Taha, Markus Knuf, Victoria Abbing-Karahagopian, Michele Pellegrini, Rafik Bekkat-Berkani, Véronique Abitbol
Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations. Pathogens and global health (2021)
Anand P Dubey, Rashna Dass Hazarika, Véronique Abitbol, Shafi Kolhapure, Someya Agrawal
Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context. Human vaccines & immunotherapeutics 17 (7) (2021)
Ashok Kumar Dutta, Subramanian Swaminathan, Véronique Abitbol, Shafi Kolhapure, Sripriya Sathyanarayanan
A Comprehensive Review of Meningococcal Disease Burden in India. Infectious diseases and therapy 9 (3) (2020)